Skip to main content
. 2020 Dec 10;8:614354. doi: 10.3389/fped.2020.614354

Table 2B.

Basic laboratory findings.

JIA patients treated with MTX JIA patients treated with MTX/ADA Healthy controls Significance (p-value)
Immunoglobulin G (g/l) 11.33 ± 2.68 11.42 ± 2.14 11.13 ± 1.91 0.962
0.896
0.991
Immunoglobulin A (g/l) 1.77 ± 0.98 1.65 ± 1.01 1.49 ± 0.83 0.659
0.840
0.916
Immunoglobulin M (g/l) 1.24 ± 0.73 1.38 ± 0.58 1.14 ± 0.73 0.903
0.454
0.802
C3 (g/l) 1.24 ± 0.22 1.22 ± 0.13 1.30 ± 0.22 0.492
0.242
0.951
C4 (g/l) 0.23 ± 0.08 0.22 ± 0.06 0.23 ± 0.08 0.995
0.930
0.969
CH50 (U/ml) 51.30 ± 24.85 50.44 ± 17.15 66.28 ± 30.52 0.189
0.091
0.994

Data are means ± standard deviation. p1 = MTX and control, p2 = MTX/ADA and control, p3 = MTX and MTX/ADA.